SHBG and neoplasm: For instance, Lin et al. (2013) [4] found that higher circulating testosterone and Sex Hormone-Binding Globulin (SHBG) levels were associated with lower CRC risk in men, while Harbs et al. (2022) [3] further emphasized sex-based differences in hormonal pathways influencing tumor biology and the response to inflammation.